Transient Photoreceptor Deconstruction by CNTF Enhances rAAV-Mediated Cone Functional Rescue in Late Stage CNGB3-Achromatopsia
Year: 2013
Type: article
Abstract: Achromatopsia is a genetic disorder of cones, and one of the most common forms is a channelopathy caused by mutations in the β-subunit, CNGB3, of the cone cyclic nucleotide-gated (CNG) channel. Recombinant adeno-associated virus of serotype 5 (rAAV5)-mediated gene transfer of human CNGB3 cDNA to mutant dog cones results in functional and structural rescue in dogs <0.5 years of age, but treatment is minimally effective in dogs >1 year. We now test a new therapeutic concept by combining gene therapy with the administration of ciliary neurotrophic factor (CNTF). Intravitreal CNTF causes transient dedifferentiation of photoreceptors, a process called deconstruction, whereby visual cells become immature with short outer segments, and decreased retinal function and gene expression that subsequently return to normal. Cone function was successfully rescued in all mutant dogs treated between 14 and 42 months of age with this strategy. CNTF-mediated deconstruction and regeneration of the photoreceptor outer segments prepares the mutant cones optimally for gene augmentation therapy.
Source: Molecular Therapy
DOI: 10.1038/mt.2013.50
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
Funders: U.S. Department of Defense, Research to Prevent Blindness, University of Southern California, University of Pennsylvania, Macula Vision Research Foundation, Michigan State University, Johns Hopkins University, Hope For Vision, National Institutes of Health, College of Engineering, Michigan State University, U.S. Public Health Service, National Eye Institute
Awards: G1018118523, G2606015775, G4218602443, CNTF and retinal degeneration: the role of Muller cells, VISION RESEARCH CORE, G6393268474, Retinal Gene Delivery by Adeno-Associated Virus, Translational Research for Retinal Degeneration Therapies, Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa, PENN Vision Clinical Scientist Program, Research Training in Vision Science, P30 Core Grant For Vision Research, Miami Center for Vision Research, Achromatopsia - Disease Mechanisms and Cone-Directed Gene Therapy
OpenAlex ID: W1968937480
